Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 71.45

+2.8%

Nov 10 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2674)	5/13/2010 1:01:03 PM
From: Jibacoa	Read Replies (1) of 3722

SOMX was up 10.26% and is still up 8.58% on volume of 1.8M about 1/3 its ADV bigcharts.marketwatch.com The stock is trying to get off the near term DT coming from its March18 H at $10.60 bigcharts.marketwatch.com The March 18 spike was when it announced that the FDA had approved the NNDA for Silenor for the treatment of insomnia characterized by difficulty with sleep maintenance.(Sleep maintenance difficulty is defined as waking frequently during the night and/or waking too early and being unable to return to sleep.).<g> Silenor is approved for the treatment of both transient (short term) and chronic (long term) insomnia. March 18 was also when it announced its 4thQ and full Yr. results.<g> For the Yr. the loss was $14.4M ($0.69/shr)vs, $37.2M ($2.04/shr) in 2008 For the 4thQ the loss was $1.9M ($0.08/shr) vs. $9.5M ($0.52/shr) As a development stage pharmaceutical company, SOMX had no revenues in 2009. <g> SOMX took advantage of the spike to sell a few days later 6M shrs at $8.25 <g> SOMX had $5.2M in cash as of Dec31 and had said it had sufficient funds to operate through the 2ndQ of 2010.<g> The first resistance is now at the $8 level and then the March18 H at $10.60 This week SOMX reported result for the 1stQ in which it was able to trim its loss from $0.25 to $0.16 As a development stage pharmaceutical company, it had no revenues during the 1stQ.<g> The ACTAY is $12.50, which with some good news it may be doable. But SOMX has a good amount of resistance from the $10 to the $15 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next